法国全国肥胖人群减重手术后结直肠癌风险研究
这项基于法国全国电子健康数据的回顾性队列研究纳入1 045 348名50至75岁肥胖个体,比较减重手术组(74 131例)与非手术组(971 217例)的结直肠癌发生风险。结果显示减重手术组结直肠癌标准化发病比为1.0(95%CI 0.90-1.09),与非手术组的1.34(95%CI 1.32-1.36)相比,提示手术后风险与一般人群相当,而未手术者风险高出34%。
要点
- 减重手术组结直肠癌风险与一般人群相当(SIR 1.0,95%CI 0.90-1.09)。
- 未手术肥胖人群结直肠癌风险高于一般人群34%(SIR 1.34,95%CI 1.32-1.36)。
- 倾向评分匹配后手术组结直肠癌风险比为0.68(95%CI 0.60-0.77)。
核心结论
- 减重手术后肥胖患者结直肠癌风险与一般人群相同,而未手术肥胖患者风险比一般人群高34%。
研究设计与样本
- 法国全国电子健康数据回顾性、人群基础、多中心队列研究,纳入1 045 348名50至75岁基线无结直肠癌的肥胖个体。
- 减重手术组74 131例,非手术组971 217例,平均随访分别约5.7年和5.3年,并行倾向评分匹配比较。
主要发现
- 共诊断13 052例结直肠癌(1.2%)和63 649例结直肠良性息肉。
- 减重手术组结直肠癌发生率为0.6%,非手术组为1.3%。
- 非手术组期望9417例 vs 观察12 629例,SIR 1.34(95%CI 1.32-1.36);手术组期望428例 vs 观察423例,SIR 1.0(95%CI 0.90-1.09)。
- 倾向评分匹配后结直肠癌风险比0.68(95%CI 0.60-0.77),结直肠良性息肉风险比0.56(95%CI 0.53-0.59)。
- 胃旁路术后结直肠癌新诊断123/22 343(0.5%),袖状胃切除术后185/35 328(0.5%),可调节胃束带术后115/16 460(0.7%)。
关键数值与推荐
- 减重手术包括可调节胃束带、袖状胃切除和胃旁路术。
- 主要结局为结直肠癌发生率,次要结局为结直肠良性息肉发生率。
临床怎么用
- 对肥胖患者,减重手术可能与结直肠癌风险降低相关,未手术者应重视结直肠癌筛查。
- 不同减重术式间结直肠癌和良性息肉发生率存在差异,需结合个体情况选择术式。
局限性
- 回顾性观察性设计,可能存在残余混杂。
- 仅纳入住院期间有记录的肥胖患者,随访依赖行政数据库。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Although bariatric surgery is effective against morbid obesity, the association of this surgery with the risk of colorectal cancer remains controversial. OBJECTIVE: To assess whether bariatric surgery is associated with altered risk of colorectal cancer among individuals with obesity. DESIGN, SETTING, AND PARTICIPANTS: This retrospective, population-based, multicenter, cohort study based on French electronic health data included 1 045 348 individuals with obesity, aged 50 to 75 years, and free of colorectal cancer at baseline. All inpatients with obesity having data recorded during a hospital stay between 2009 and 2018 by the French national health insurance information system database were followed up for a mean (SD) of 5.3 (2.1) years for those who did not undergo bariatric surgery and 5.7 (2.2) years for those who underwent bariatric surgery. Two groups of patients comparable in terms of age, sex, body mass index, follow-up, comorbidities, and conditions who did or did not undergo surgery were also obtained by propensity score matching. EXPOSURES: Bariatric surgery (n = 74 131), including adjustable gastric banding, sleeve gastrectomy, gastric bypass; or no bariatric surgery (n = 971 217). MAIN OUTCOMES AND MEASURES: Primary outcome was incident colorectal cancer. Standardized incidence ratios were calculated using age-, sex-, and calendar year-matched colorectal cancer incidence among the general French population during the corresponding years. Secondary outcome was incident colorectal benign polyps. RESULTS: Among a total of 1 045 348 patients, the mean (SD) age was 57.3 (5.5) years for the 74 131 patients in the surgical cohort vs 63.4 (7.0) years for the 971 217 patients in the nonsurgical cohort. The mean (SD) follow-up was 6.2 (2.1) years for patients who underwent adjustable gastric banding, 5.5 (2.1) years for patients who underwent sleeve gastrectomy, and 5.7 (2.2) years for patients who underwent gastric bypass. In total, 13 052 incident colorectal cancers (1.2%) and 63 649 colorectal benign polyps were diagnosed. The rate of colorectal cancer was 0.6% in the bariatric surgery cohort and 1.3% in the cohort without bariatric surgery. In the latter cohort, 9417 cases were expected vs 12 629 observed, a standardized incidence ratio of 1.34 (95% CI, 1.32-1.36). In the bariatric surgery cohort, 428 cases were expected and 423 observed, a standardized incidence ratio of 1.0 (95% CI, 0.90-1.09). Propensity score-matched hazard ratios in comparable operated vs nonoperated groups were 0.68 (95% CI, 0.60-0.77) for colorectal cancer and 0.56 (95% CI, 0.53-0.59) for colorectal benign polyp. There were fewer new diagnoses of colorectal cancer after gastric bypass (123 of 22 343 [0.5%]) and sleeve gastrectomy (185 of 35 328 [0.5%]) than after adjustable gastric banding (115 of 16 460 [0.7%]), and more colorectal benign polyps after adjustable gastric banding (775 of 15 647 [5.0%]) than after gastric bypass (639 of 20 863 [3.1%]) or sleeve gastrectomy (1005 of 32 680 [3.1%]). CONCLUSION AND RELEVANCE: The results of this nationwide cohort study suggested that following bariatric surgery, patients with obesity share the same risk of colorectal cancer as the general population, whereas for patients with obesity who do not undergo bariatric surgery, the risk is 34% above that of the general population.
引用
- Bailly L, Fabre R, Pradier C, et al. Colorectal Cancer Risk Following Bariatric Surgery in a Nationwide Study of French Individuals With Obesity. JAMA Surg. 2020. PMID: 32159744. doi:10.1001/jamasurg.2020.0089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。